The Family Firm’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-581
Closed -$253K 115
2025
Q1
$253K Sell
581
-44
-7% -$17.7K 0.06% 186
2024
Q4
$231K Sell
625
-19
-3% -$7.95K 0.05% 192
2024
Q3
$335K Buy
644
+1
+0.2% +$534 0.07% 154
2024
Q2
$348K Buy
643
+2
+0.3% +$1.06K 0.08% 145
2024
Q1
$333K Buy
641
+1
+0.2% +$497 0.08% 148
2023
Q4
$302K Buy
640
+17
+3% +$7.86K 0.08% 145
2023
Q3
$271K Buy
623
+2
+0.3% +$907 0.08% 141
2023
Q2
$276K Buy
621
+1
+0.2% +$461 0.07% 148
2023
Q1
$285K Buy
620
+5
+0.8% +$2.38K 0.08% 146
2022
Q4
$315K Buy
615
+37
+6% +$18.8K 0.09% 140
2022
Q3
$262K Sell
578
-20
-3% -$9.57K 0.08% 147
2022
Q2
$288K Buy
598
+1
+0.2% +$495 0.08% 147
2022
Q1
$293K Buy
597
+1
+0.2% +$457 0.08% 144
2021
Q4
$276K Buy
596
+1
+0.2% +$421 0.07% 149
2021
Q3
$252K Buy
595
+2
+0.3% +$760 0.07% 153
2021
Q2
$227K Buy
593
+1
+0.2% +$382 0.06% 166
2021
Q1
$213K Buy
+592
New +$190K 0.06% 167

Other funds holding ELV

The Family Firm's ELV Position: Q2 2025 in Review

The Family Firm sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 581 shares — an estimated $253K sold.

The Family Firm first reported a position in ELV in Q1 2021 and held it in 17 quarters. The position peaked at $348K in Q2 2024. 1,590 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • The Family Firm reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • The Family Firm sold 581 Elevance Health shares in Q2 2025, an estimated $253K.
  • The Family Firm first reported a position in Elevance Health in Q1 2021 and held it in 17 quarters.
  • The Family Firm's Elevance Health position peaked at $348K in Q2 2024.
  • 1,590 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on The Family Firm's 13F filing for Q2 2025, filed 8 Aug 2025.